Marek Stefan , Suhanya Prasad , Ivana Vitkova , Elka Nycova , Lenka Ryskova , Pavla Kucova , Lenka Geigerova , Denisa Vesela , Magda Balejova , Natasa Bartonikova , Lenka Havlinova , Erika Czyzova , Jan Kubele , Barbora Dratvova , Milena Antuskova , Jaroslava Zikova , Marie Brajerova , Otakar Nyc , Milan Trojanek , Pavel Drevinek , Marcela Krutova
{"title":"A post-COVID-19 upsurge in Group A Streptococcus in the Czech Republic was driven by emm1 and emm12 with shared virulence factors","authors":"Marek Stefan , Suhanya Prasad , Ivana Vitkova , Elka Nycova , Lenka Ryskova , Pavla Kucova , Lenka Geigerova , Denisa Vesela , Magda Balejova , Natasa Bartonikova , Lenka Havlinova , Erika Czyzova , Jan Kubele , Barbora Dratvova , Milena Antuskova , Jaroslava Zikova , Marie Brajerova , Otakar Nyc , Milan Trojanek , Pavel Drevinek , Marcela Krutova","doi":"10.1016/j.jiph.2025.102886","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In 2023, a significant increase in <em>Streptococcus pyogenes</em>, Group A <em>Streptococcus</em> (GAS) culture positivity was observed in Czech microbiological laboratories. We conducted a multicentre study to obtain epidemiological data and characterise circulating strains.</div></div><div><h3>Methods</h3><div>Eleven microbiology departments provided data on single-patient GAS-positive cultures from 2017 to 2023. Additionally, 10 consecutive, single-patient GAS isolates from 12 hospitals were submitted in May 2023 for whole-genome sequencing and antimicrobial susceptibility testing.</div></div><div><h3>Results</h3><div>In 2023, there was a significant increase in GAS-positive cultures compared to the periods of 2017–2019 (p = 0.002), 2020–2021 (p < 0.00001), and 2022 (p = 0.001), with a disproportionate increase in children. Among 120 isolates, 12 different <em>emm</em> types and 16 multi-locus sequence types (STs) were identified, with <em>emm</em>1 (ST28, 35.0 %) and <em>emm</em>12 (STs 36, 101, 242, 1366, 32.5 %) being the most prevalent. Clonal clustering of <em>emm</em>1 and <em>emm</em>12 isolates across different study sites and geographic regions was demonstrated by whole-genome MLST analysis. When searching for shared virulence genes exclusive to <em>emm</em>1 and <em>emm</em>12 but absent in other <em>emm</em> types, immune evasion and colonisation factors (the streptococcal inhibitor of complement-<em>sic</em> gene in <em>emm</em>1, the distantly related sic-<em>drs</em> gene in <em>emm</em>12, and the <em>sda</em>1 gene in both) were identified.</div></div><div><h3>Conclusions</h3><div>An upsurge in GAS infections, predominantly caused by <em>emm</em>1 and <em>emm</em>12, was identified in the Czech Republic. The combination of shared virulence factors, altered herd immunity and naïve immunity in children, resulting from contact precautions measures during the COVID-19 pandemic, may have contributed to their increased spread.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 10","pages":"Article 102886"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002357","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
In 2023, a significant increase in Streptococcus pyogenes, Group A Streptococcus (GAS) culture positivity was observed in Czech microbiological laboratories. We conducted a multicentre study to obtain epidemiological data and characterise circulating strains.
Methods
Eleven microbiology departments provided data on single-patient GAS-positive cultures from 2017 to 2023. Additionally, 10 consecutive, single-patient GAS isolates from 12 hospitals were submitted in May 2023 for whole-genome sequencing and antimicrobial susceptibility testing.
Results
In 2023, there was a significant increase in GAS-positive cultures compared to the periods of 2017–2019 (p = 0.002), 2020–2021 (p < 0.00001), and 2022 (p = 0.001), with a disproportionate increase in children. Among 120 isolates, 12 different emm types and 16 multi-locus sequence types (STs) were identified, with emm1 (ST28, 35.0 %) and emm12 (STs 36, 101, 242, 1366, 32.5 %) being the most prevalent. Clonal clustering of emm1 and emm12 isolates across different study sites and geographic regions was demonstrated by whole-genome MLST analysis. When searching for shared virulence genes exclusive to emm1 and emm12 but absent in other emm types, immune evasion and colonisation factors (the streptococcal inhibitor of complement-sic gene in emm1, the distantly related sic-drs gene in emm12, and the sda1 gene in both) were identified.
Conclusions
An upsurge in GAS infections, predominantly caused by emm1 and emm12, was identified in the Czech Republic. The combination of shared virulence factors, altered herd immunity and naïve immunity in children, resulting from contact precautions measures during the COVID-19 pandemic, may have contributed to their increased spread.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.